普洛药业：关于获得化学原料药欧洲CEP证书的公告

Core Viewpoint - Prolo Pharmaceutical's wholly-owned subsidiary, Zhejiang Prolo Jiayuan Pharmaceutical Co., Ltd., has received the Certificate of Suitability (CEP) for Venlafaxine Hydrochloride from the European Medicines Agency [2] Group 1 - The CEP certificate indicates that the product meets the European Pharmacopoeia standards, which is crucial for market access in Europe [2] - This certification may enhance the company's competitive position in the European pharmaceutical market [2] - The approval reflects the company's commitment to quality and regulatory compliance in its product offerings [2]